Stock GTHP GUIDED THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Guided Therapeutics, Inc.

Equities

GTHP

US40171F5017

Market Closed - OTC Markets
Other stock markets
 20:59:37 29/05/2024 BST 		5-day change 1st Jan Change
0.1 USD -8.26% Intraday chart for Guided Therapeutics, Inc. +24.22% -34.85%
05-14 Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-28 Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Leading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial Results
BU
Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval
BU
Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval
CI
Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Guided Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Guided Therapeutics Provides Update on Start of Clinical Trial for US FDA Approval
BU
Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
GUIDED THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS (form 10-K)
AQ
Guided Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
CI
Guided Therapeutics Announces New Agreement and Purchase Orders from Shandong Yaohua Medical Instrument Corporation
BU
Guided Therapeutics, Inc. Announces CEO Changes
CI
Guided Therapeutics, Inc. Announces Executive Changes
CI
GUIDED THERAPEUTICS INC : Change in Directors or Principal Officers (form 8-K)
AQ
Guided Therapeutics Signs Agreement to Begin Clinical Trial for US FDA Approval
BU
Guided Therapeutics Signs Agreement to Begin Clinical Trial for US FDA Approval
CI
GUIDED THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GTHP Stock
  4. News Guided Therapeutics, Inc.